4//SEC Filing
Leonite Capital LLC 4
Accession 0001209191-22-047714
CIK 0001841330other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 4:30 PM ET
Size
9.1 KB
Accession
0001209191-22-047714
Insider Transaction Report
Form 4
Leonite Fund I, LP
Other
Transactions
- Purchase
Common Stock
2022-08-19$1.30/sh+54,644$70,939→ 54,644 total(indirect: See footnote)
Holdings
- 1,034,702(indirect: See footnote)
Common Stock
Leonite Capital LLC
10% OwnerOther
Transactions
- Purchase
Common Stock
2022-08-19$1.30/sh+54,644$70,939→ 54,644 total(indirect: See footnote)
Holdings
- 1,034,702(indirect: See footnote)
Common Stock
Geller Avi
10% OwnerOther
Transactions
- Purchase
Common Stock
2022-08-19$1.30/sh+54,644$70,939→ 54,644 total(indirect: See footnote)
Holdings
- 1,034,702(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]The shares are held by Leonite Fund I, LP. Avi Geller is the Managing Member of Leonite Advisors LLC, which is the General Partner of Leonite Fund I, LP.
- [F2]The shares are held by Leonite Capital LLC, of which Avi Geller serves as Chief Investment Officer.
Documents
Issuer
Pasithea Therapeutics Corp.
CIK 0001841330
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001824520
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 4:30 PM ET
- Size
- 9.1 KB